INFO60
SpotlightTopics60sNEWQuizLogin
IndiaAI & TechBusinessTechnologySportsEntertainmentHealthScienceWorld
INFO60

Know more. Read less. What matters, fast.

Company

  • About
  • Contact
  • Editorial Policy
  • Corrections
  • Our desks
  • Publishers

Legal

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Account

  • Delete Account
  • Spotlight
  • Quick Cards
  • Topics
  • Web Stories
  • Hindi News

Free. One email a day. Unsubscribe anytime.

Editions

  • India
  • United States
  • United Kingdom
  • Canada
  • Australia
  • UAE & Gulf
  • Singapore
  • Hindi
  • All countries
© 2026 Info60. All rights reserved.
Home›health›Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026
health

Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026

By Info60 World Desk•Summary of reporting by Businesswire•Sep 22, 2026•0 views•
Medpace Holdings, Inc. to Report Third Quarter 2026 Financial Results on October 21, 2026
CINCINNATI--(BUSINESS WIRE)--Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its third quarter 2026 financial results after the market close on Wednesday, October 21, 2026. The Company will host a conference call the following morning, Thursday, October 22, 2026, at 9:00 a.m. ET to discuss these results. To participate in the conference call, interested parties must register in advance by clicking on this link. While it is not required, it is recommended yo
ONLY AVAILABLE IN PAID PLANS
Read Full Article

Share this story

Report an error

Up next

Related Stories

Amesite Announces New Sales Win Under NurseMagic® Minimum Enterprise Pricing Model

Globenewswire_fr

aTyr Pharma Announces Alignment with FDA on Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis

Globenewswire_fr

Biodesix Advances Two Complementary Approaches to Molecular Residual Disease (MRD) Monitoring

Globenewswire_fr

Adventure With a Purpose: A Race Against Blindness Unveils Adventure Package Fundraiser Valued at $350,000

Globenewswire_fr

Re: Management of paracetamol (acetaminophen) toxicity

Bmj

Comments (0)

Please login to comment

Login
💬

No comments yet. Be the first to comment!